New Protocols (3*)
* The protocols may appear repeatedly under different diseasesBile Duct Carcinoma
Lung Carcinoma, Non-Small Cell
Breast Cancer
Nasopharyngeal Carcinoma
Pancreatic Cancer
Tumor Biomarker Defined
Updated Protocols (0*)
* The protocols may appear repeatedly under different diseasesProtocols in Revision
Breast Cancer
- Sacituzumab Govitecan 10, Breast Cancer PID 1780 V1.3
Multiple Myeloma
- Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 1 PID 41 V1.2
- Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 2-3 PID 42 V1.2
Nasopharyngeal Carcinoma
- PAED Cisplatin 100 / Folinic Acid 25 / Fluorouracil 1000, Nasopharyngeal Carcinoma, Part A PID 723 V1.3
Prostate Cancer
- Abirateron 1000 / Prednisolon 5 / Goserelin 10,8, Prostatakarzinom PID 1002 V1.2
- Abiraterone 1000 / Prednisolone 5, Prostate Cancer Hormone Sensitive PID 1504 V1.2
- Docetaxel 50 / Prednisolon 5, Prostatakarzinom PID 941 V1.2
- Docetaxel 75 / Darolutamid 600 / Goserelin 10,8 - Darolutamid 600 / Goserelin 10,8, Prostatakarzinom hormonsensitiv, Erhaltung PID 2081 V1.1
- Docetaxel 75 / Darolutamid 600 / Goserelin 10,8, Prostatakarzinom hormonsensitiv, Zyklus 1 PID 2040 V1.2
- Docetaxel 75 / Darolutamid 600 / Goserelin 10,8, Prostatakarzinom hormonsensitiv, Zyklus 2 PID 2041 V1.2
- Docetaxel 75 / Prednisolon 5 / Abirateron 1000 / Goserelin 10,8, Prostatakarzinom hormonsensitiv, Zyklus 2 PID 2306 V1.1
- Docetaxel 75 / Prednisolon 5 / Goserelin 10,8 - Goserelin 10,8, Prostatakarzinom hormonsensitiv, Erhaltung PID 2082 V1.2
- Docetaxel 75 / Prednisolon 5 / Goserelin 10,8, Prostatakarzinom hormonsensitiv, Zyklus 1 PID 641 V2.1
- Docetaxel 75 / Prednisolon 5 / Goserelin 10,8, Prostatakarzinom hormonsensitiv, Zyklus 2 PID 664 V2.1
